» Articles » PMID: 20117004

Synthesis, Structure-activity Relationship and Crystallographic Studies of 3-substituted Indolin-2-one RET Inhibitors

Overview
Journal Bioorg Med Chem
Specialties Biochemistry
Chemistry
Date 2010 Feb 2
PMID 20117004
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The synthesis, structure-activity relationships (SAR) and structural data of a series of indolin-2-one inhibitors of RET tyrosine kinase are described. These compounds were designed to explore the available space around the indolinone scaffold within RET active site. Several substitutions at different positions were tested and biochemical data were used to draw a molecular model of steric and electrostatic interactions, which can be applied to design more potent and selective RET inhibitors. The crystal structures of RET kinase domain in complex with three inhibitors were solved. All three compounds bound in the ATP pocket and formed two hydrogen bonds with the kinase hinge region. Crystallographic analysis confirmed predictions from molecular modelling and helped refine SAR results. These data provide important information for the development of indolinone inhibitors for the treatment of RET-driven cancers.

Citing Articles

Structure-Based QSAR Modeling of RET Kinase Inhibitors from 49 Different 5,6-Fused Bicyclic Heteroaromatic Cores to Patent-Driven Validation.

Jin S, Kumar S, Kim M ACS Omega. 2024; 9(50):49662-49673.

PMID: 39713648 PMC: 11656239. DOI: 10.1021/acsomega.4c07843.


Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)--substituted benzene sulfonamides.

Kumar M, Ramasamy K, Mani V, Mishra R, Majeed A, De Clercq E Arab J Chem. 2024; 7(4):396-408.

PMID: 38620260 PMC: 7185680. DOI: 10.1016/j.arabjc.2012.12.005.


Synthesis biological evaluation and molecular docking of isatin hybrids as anti-cancer and anti-microbial agents.

Altamimi M, Syed S, Tuzun B, Alhazani M, Alnemer O, Bari A J Enzyme Inhib Med Chem. 2023; 39(1):2288548.

PMID: 38073431 PMC: 11721758. DOI: 10.1080/14756366.2023.2288548.


Design and Synthesis of Novel Thieno[3,2-]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells.

La Monica G, Pizzolanti G, Baiamonte C, Bono A, Alamia F, Mingoia F ACS Omega. 2023; 8(38):34640-34649.

PMID: 37779971 PMC: 10536062. DOI: 10.1021/acsomega.3c03578.


Identification of potential biological targets of oxindole scaffolds via repositioning strategies.

Tinivella A, Pinzi L, Gambacorta G, Baxendale I, Rastelli G F1000Res. 2023; 11.

PMID: 37767081 PMC: 10521104. DOI: 10.12688/f1000research.109017.2.